NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

神經調節的全球市場:產業分析,趨勢,市場規模,預測 (2027年)

Neuromodulation Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

出版商 Infinium Global Research (IGR) 商品編碼 1022557
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
神經調節的全球市場:產業分析,趨勢,市場規模,預測 (2027年) Neuromodulation Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027
出版日期: 2021年07月01日內容資訊: 英文 100 Pages
簡介

全球神經調節市場在2021年∼2027年的預測期間內,預計將以年複合成長率10.9%的速度成長。

本報告提供全球神經調節市場相關調查分析,提供推動市場要素,阻礙因素,機會,需求的要素,市場規模,預測,趨勢等相關的系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 全球神經調節市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • COVID-19對神經調節市場的影響分析
  • 波特的五力分析
  • IGR - 成長矩陣分析
  • 神經調節市場價值鏈分析

第4章 神經調節市場宏觀指標分析

第5章 全球神經調節市場:各技術

  • 腦深部刺激
  • 脊髓刺激
  • 胃刺激
  • 薦椎神經刺激
  • 迷走神經刺激
  • 其他

第6章 全球神經調節市場:各適應症

  • 慢性疼痛
  • 帕金森氏症
  • 肌張力不全症
  • 原發性顫抖症
  • 難治性癲癇
  • 治療反抗性憂鬱症 (TRD)
  • 大小便失禁
  • 其他

第7章 全球神經調節市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 企業簡介和競爭情形

  • 全球神經調節市場上競爭情形
  • 企業簡介
    • Medtronic Plc
    • Boston Scientific Corporation
    • St. Jude Medical
    • Cyberonics
    • Cochlear Ltd.
    • Advanced Bionics
    • Sonova Group
    • Nevro Corporation
    • Neuronetics, Inc.
    • Greatbatch
目錄
Product Code: HC08692

The report on the global neuromodulation market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global neuromodulation market to grow with a CAGR of 10.9% over the forecast period from 2021-2027. The study on neuromodulation market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on neuromodulation market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global neuromodulation market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global neuromodulation market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rise in the base of the geriatric population
  • An increasing number of patients with neurological disorders

2) Restraints

  • Lack of a sufficient number of trained professionals to treat disorders

3) Opportunities

  • A strong product pipeline with various innovations

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global neuromodulation market is segmented on the basis of technology, and application.

The Global Neuromodulation Market by Technology

  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Gastric Stimulation
  • Sacral Nerve Stimulation
  • Vagus Nerve Stimulation
  • Others

The Global Neuromodulation Market by Application

  • Chronic Pain
  • Parkinson's Disease
  • Dystonia
  • Essential Tremor
  • Refractory Epilepsy
  • Treatment Resistant Depression(TRD)
  • Urinary Fecal Incontinence
  • Other Applications

Company Profiles

The companies covered in the report include

  • Medtronic Plc
  • Boston Scientific Corporation
  • St. Jude Medical
  • Cyberonics
  • Cochlear Ltd.
  • Advanced Bionics
  • Sonova Group
  • Nevro Corporation
  • Neuronetics, Inc.
  • Greatbatch

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the neuromodulation market.

2. Complete coverage of all the segments in the neuromodulation market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global neuromodulation market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Neuromodulation Market Highlights
  • 2.2. Neuromodulation Market Projection
  • 2.3. Neuromodulation Market Regional Highlights

3. Global Neuromodulation Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Neuromodulation Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Technology
    • 3.5.2. IGR-Growth Matrix Analysis by Application
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Neuromodulation Market

4. Neuromodulation Market Macro Indicator Analysis

5. Global Neuromodulation Market by Technology

  • 5.1. Deep Brain Stimulation
  • 5.2. Spinal Cord Stimulation
  • 5.3. Gastric Stimulation
  • 5.4. Sacral Nerve Stimulation
  • 5.5. Vagus Nerve Stimulation
  • 5.6. Others

6. Global Neuromodulation Market by Application

  • 6.1. Chronic Pain
  • 6.2. Parkinson's Disease
  • 6.3. Dystonia
  • 6.4. Essential Tremor
  • 6.5. Refractory Epilepsy
  • 6.6. Treatment Resistant Depression (TRD)
  • 6.7. Urinary Fecal Incontinence
  • 6.8. Other Applications

7. Global Neuromodulation Market by Region 2021-2027

  • 7.1. North America
    • 7.1.1. North America Neuromodulation Market by Technology
    • 7.1.2. North America Neuromodulation Market by Application
    • 7.1.3. North America Neuromodulation Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Neuromodulation Market by Technology
    • 7.2.2. Europe Neuromodulation Market by Application
    • 7.2.3. Europe Neuromodulation Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Neuromodulation Market by Technology
    • 7.3.2. Asia-Pacific Neuromodulation Market by Application
    • 7.3.3. Asia-Pacific Neuromodulation Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Neuromodulation Market by Technology
    • 7.4.2. RoW Neuromodulation Market by Application
    • 7.4.3. RoW Neuromodulation Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Neuromodulation Market
  • 8.2. Companies Profiles
    • 8.2.1. Medtronic Plc
    • 8.2.2. Boston Scientific Corporation
    • 8.2.3. St. Jude Medical
    • 8.2.4. Cyberonics
    • 8.2.5. Cochlear Ltd.
    • 8.2.6. Advanced Bionics
    • 8.2.7. Sonova Group
    • 8.2.8. Nevro Corporation
    • 8.2.9. Neuronetics, Inc.
    • 8.2.10. Greatbatch